MINI FUTURE LONG - YPSOMED N Share Price

Certificat

DE000MG69WF5

Market Closed - Börse Stuttgart 06:23:03 03/07/2024 pm IST
23.91 EUR +3.55% Intraday chart for MINI FUTURE LONG - YPSOMED N
Current month+1.36%
Date Price Change
03/24/03 23.91 +3.55%
02/24/02 23.09 -3.91%
01/24/01 24.03 +1.87%
28/24/28 23.59 -1.83%
27/24/27 24.03 +2.52%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 06:23 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying YPSOMED HOLDING AG
Issuer Morgan Stanley
WKN MG69WF
ISINDE000MG69WF5
Date issued 19/06/2024
Strike 182.6 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 22.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.03
Lowest since issue 21.27

Company Profile

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Sector
-
More about the company

Ratings for Ypsomed Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Ypsomed Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
411 CHF
Average target price
378 CHF
Spread / Average Target
-8.03%
Consensus